{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-069625","form_type":"8-K","ticker":"TVRD","cik":"0001346830","company_name":"Tvardi Therapeutics, Inc.","filed_at":"2024-06-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.035566+00:00","generated_at":"2026-06-01T05:30:14.796484+00:00","sec_items":["5.03","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"CARA shareholders approve doubling authorized shares and authorize reverse stock split","bullets":["Authorized common stock increased from 100M to 200M shares; 76.5% of votes in favor.","Board authorized to implement reverse stock split at ratio 1:4 to 1:12, with proportionate reduction in authorized shares.","Directors Susan Shiff and Helen Boudreau elected; advisory say-on-pay passed with 16.3M for vs 10.7M against.","Ernst & Young ratified as independent auditor for FY2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-069625","json":"https://secwatch.observer/filing/0001104659-24-069625.json","markdown":"https://secwatch.observer/filing/0001104659-24-069625.md","text":"https://secwatch.observer/filing/0001104659-24-069625.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1346830/000110465924069625/0001104659-24-069625-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1346830/000110465924069625/tm2416682d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T05:30:14.796484+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}